Effect of XYLA ointment on episiotomy
Phase 3
- Conditions
- Episiotomy.Disruption of perineal obstetric wound
- Registration Number
- IRCT20160830029608N2
- Lead Sponsor
- Fasa University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 100
Inclusion Criteria
More than 37 weeks gestational age
normal pregnancy,
singleton
cephalic presentation
Exclusion Criteria
hypersensitivity to topical anesthetics or lidocaine
,epidertal anesthesia
heart disease
diabetes
ncontrolled and neurological diseases involving lower limbs
use of systemic or inhaled opioids to reduce pain during labor
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Severity of pain during episiotomy. Timepoint: Immediately after episiotomy repair. Method of measurement: The Visual Analog Scale (VAS) is a vertical 10-cm linear scale, with zero indicating pain-free pain and 10 indicating maximum pain. Patient's satisfaction with Likert scale retrieval method is also 5 (very satisfied, dissatisfied, dissatisfied, dissatisfied, dissatisfied and completely dissatisfied).
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie EMLA's efficacy in postpartum perineal pain management compared to mepivacaine infiltration?
How does mepivacaine infiltration compare to EMLA in terms of pain relief onset and duration for episiotomy repair in IRCT20160830029608N2?
Are there specific biomarkers or patient characteristics predicting response to lidocaine-prilocaine cream versus mepivacaine in perineal wound healing?
What adverse events are associated with EMLA and mepivacaine infiltration in postpartum women, and how are they managed in clinical practice?
What alternative local anesthetics or combination therapies are being explored for perineal pain relief in normal vaginal deliveries alongside IRCT20160830029608N2?